Purchase Order 75N91018P00328

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,660.00 on June 27, 2017, for laboratory supplies. Performance occurs in Pleasanton, California, with an ultimate completion date of July 21, 2017. The order covers 10X Genomics single-cell and spatial transcriptomics reagents and consumables supplied under firm fixed price, with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 15, 2018, with ultimate completion on April 13, 2018. The order covers laboratory supplies under firm fixed price terms. Place of performance is Pleasanton, California.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. for $22,366.00 in lab supplies, awarded August 15, 2017, with completion by September 13, 2017. Performance occurs at 10X Genomics' facility in Pleasanton, California. The order is firm fixed price with no set-aside category.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on May 30, 2018, for lab supplies. Performance occurs at the vendor's facility in Pleasanton, California. The order carries a firm fixed price and is scheduled for completion by June 28, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for lab supplies valued at $5,847.00 on January 4, 2018, with completion targeted for February 2, 2018. Performance occurs in Pleasanton, California. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $5,600 on November 16, 2017, for laboratory supplies. Performance location is Pleasanton, California. The order carries a firm fixed price and ultimate completion date of December 31, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,554.00 on August 22, 2017, with a completion date of September 21, 2017. The order covers laboratory supplies, with place of performance in Pleasanton, California. Pricing is firm fixed price under a no-set-aside simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 6, 2018, for a maintenance agreement, with completion by April 4, 2018. Performance occurs in Pleasanton, California. The order is a firm fixed price acquisition with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on July 11, 2018. Work is performed in Pleasanton, California. The order carries no set-aside designation and is priced on a firm fixed price basis. Ultimate completion is scheduled for July 10, 2019.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $7,849.00 in bio products on December 12, 2017, with an ultimate completion date of January 12, 2018. Work is performed in Pleasanton, California. The order is firm fixed price with no set-aside applied.</p>